Louis H. Morrone - Dec 17, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: SENIOR VICE PRESIDENT
Signature: /s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Dec 17, 2021
Transactions value $: -$890,930
Form type: 4
Date filed: 12/21/2021, 04:38 PM
Previous filing: Dec 8, 2021
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$483K	+9.99K	+26.13%	$48.34	48.2K	Dec 17, 2021	Direct
transaction	ABT	Common shares without par value	Sale	-$1.37M	-9.99K	-20.71%	$137.54	38.2K	Dec 17, 2021	Direct
holding	ABT	Common shares without par value						2.3K	Dec 17, 2021	Profit Sharing Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-9.99K	-100%	$0.00^*	0	Dec 17, 2021	Common Shares	9.99K	$48.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance in the Abbott Laboratories Stock Retirement Trust as of December 17, 2021.
F2	Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).